Beijing Strong Biotechnologies300406.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Beijing Strong Biotechnologies (300406.SZ) trades at a P/E of 29.60x, P/B of 1.94x, P/S of 4.91x, and a dividend yield of 10.50%.
Longitudinal percentile comparison: P/E sits at the 58th percentile over the trailing 10Y window (vs. 71st percentile over 3Y); P/B sits at the 6th percentile over the trailing 10Y window (vs. 18th percentile over 3Y); P/S sits at the 4th percentile over the trailing 10Y window (vs. 13th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 40th percentile within its industry and the 41st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.50%, ranking at the 99th percentile over the trailing 20Y window.
The P/E and P/B percentiles diverge here, differing by 52.0 points — relying on either metric alone could be misleading. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Beijing Strong Biotechnologies operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 300406 · SZSE: 300406 · 300406
Want the full picture on whether Beijing Strong Biotechnologies (300406.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 29.60 | ||||||
| P/B (MRQ) | 1.94 | ||||||
| P/S (TTM) | 4.91 | ||||||
| Dividend Yield | 10.50% | ||||||
| Buyback + Div Yield | 10.50% |